Preview

Siberian Journal of Clinical and Experimental Medicine

Advanced search

Stevens – Johnson syndrome: a case report

https://doi.org/10.29001/2073-8552-2023-38-2-248-252

Abstract

The article presents a case report of Stevens-Johnson syndrome (SJS), a rare but serious pathological process with erosive mucosal lesions and widespread skin lesions. SJS is usually caused by an allergic reaction to  medications, sometimes triggers of the syndrome are infectious diseases, but often the cause cannot be determined. A disease, especially drug-induced,  can occur in practice of any specialty physicians. But it is not always  recognized in time. It often requires an individual approach to treatment. The presented clinical case confirms a need for timely diagnosis, early initiation of individual treatment. 

About the Authors

N. S. Iamkina
Siberian State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Nataliia S. Iamkina - Cand. Sci. (Med), Assistant Professor, Department of Propaedeutics of Internal Diseases with a Course of Therapy 

2, Moscovsky trakt str., Tomsk, 634050, Russian Federation 



V. V. Boyarko
Siberian State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Valentina V. Boyarko - Cand. Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Diseases with a Course of Therapy 

2, Moscovsky trakt str., Tomsk, 634050, Russian Federation 



E. V. Bukreeva
Siberian State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Ekaterina B. Bukreeva - Dr. Sci. (Med.), Professor, Department of Propaedeutics of Internal Diseases with a Course of Therapy 

2, Moscovsky trakt str., Tomsk, 634050, Russian Federation 



References

1. Dyubkova T.P., Zhernosek V.F. Stevens-Johnson syndrome – a toxic epidermal necrolysis in children. Minsk: RIBSH; 2013:205.

2. Zhernosek V.F., Dyubkova T.P. Clinical classification and diagnostic criteria of Stevens – Johnson syndrome – a toxic epidermal necrolysis in children: review of foreign literature. Pediatrics. Eastern Europe.2014;5(1):118–133. URL: https://elib.bsu.by/bitstream/123456789/215567/1/82_%D0%9A%D0%BB%D0%B8%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BA%D0%BB%D0%B0%D1%81%D1%81%D0%B8%D1%84%D0%B8%D0%BA%D0%B0%D1%86%D0%B8%D1%8F.pdf (14.12.2022).

3. Grigoriev D.V. Exudative erythema multiforme, Stevens – Johnson syndrome and Lyell syndrome are a modern interpretation of the problem. Russian Medical Journal. 2013;22:1073–1083. URL:

4. Bardenikova S.I., Pentkovskaya O.S., Isaeva E.K. Stevens – Johnson syndrome is an immune -catastrophe. Russian Journal of Woman and Child Health. 2019;2(1):66–72. URL: https://cyberleninka.ru/article/n/sindrom-stivensa-dzhonsona-immunnaya-katastrofa (14.12.2022).

5. Vertkin A.L., Dadykina A.V. Stevens-Johnson syndrome. Lechaschi Vrach. 2006;4: 79–82. URL: https://www.lvrach.ru/2006/04/4533749 (14.12.2022).

6. Pоvzun A.S., Krylov K.M., Krylov P.K., Furman I.B., Belousova I.E., Michunskii K.E. et el. Toxic epidermal necrolysis: problems of diagnosis and therapy. Intensive Care Herald. 2017;2:66–75. DOI: 10.21320/1818-474X2017-2-69-75.

7. Schöpf E., Stühmer A., Rzany B., Victor N., Zentgraf R., Kapp J.F. Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: An Epidemiologic Study From West Germany. Arch Dermatol. 1991;127(6):839–842. DOI: 10.1001/archderm.1991.01680050083008.

8. Marxer C., Frey N., Bircher A. Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A UK-based Cohort Study. Journal of Investigative Dermatology. 2020;141(6): 1016–1022. DOI: 10.1016/j.jid.2020.09.034.

9. Kim H.I., Kim S.W., Park G.Y., Kwon E.G., Kim H.H., Jeong J.Y. et al. Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients. Korean J. Intern. Med. 2012;27(2):203–210. DOI: 10.3904/kjim.2012.27.2.203.

10. Frey N., Jossi J., Bodmer M., Bircher A., Jick S.S., Meier C.R. et al. The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK. J. Invest. Dermatol. 2017;137(6):1240–1247. DOI: 10.1016/j.jid.2017.01.031.

11. Yang S.C., Hu S., Zhang S.Z., Huang J.W., Zhang J., Ji C. et al. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China. J. Immunol. Res. 2018:4320195. [published correction appears in Journal of Immunology Research. 2018:4154507]. DOI: 10.1155/2018/4320195.

12. Nurtdinova G.M., Galimova E.S., Kucher O.I., Muslimova V.K. Stevens-Johnson Syndrome. Russian Medical Journal. 2020;4(1):52–57. DOI: 10.32364/2587-6821-2020-4-1-52-57.

13. Federal Clinical Guidelines for the Management of Patients with Stevens – Johnson Syndrome/ toxic epidermal necrolysis: Federal Clinical Guidelines. Russian Society of Dermatovenerologists and Cosmetologists. Moscow; 2015:11. URL: https://www.cnikvi.ru/docs/clinic_recs/bolezni-kozhi-i-pridatkov-kozhi/%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC%20%D0%A1%D1%82%D0%B8%D0%B2%D0%B5%D0%BD-c%D0%B0-%D0%94%D0%B6%D0%BE%D0%BD-%D1%81%D0%BE%D0%BD%D0%B0.doc. (14.12.2022).

14. Toxic epidermal necrolysis (Stevens – Johnson Syndrome): Federal Clinical Guidelines.Russian Society of Dermatovenerologists and Cosmetologists. Moscow; 2016:28.

15. Hirahara K., Kano Y., Sato Y., Horie C., Okazaki A., Ishida T. et al. Methylprednisolone pulse therapy for Stevens – Johnson syndrome/ toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers. J. Am. Acad. Dermatol. 2013;(69):496–498. DOI: 10.1016/j.jaad.2013.04.007.

16. Yamane Y., Matsukura S., Watanabe Y., Yamaguchi Y., Nakamura K., Kambara T. et al. Retrospective analysis of Stevens - Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients – Treatment and outcome. Allergol. Int. 2016;65(1):74–81. DOI: 10.1016/j.alit.2015.09.001.

17. Lee H.Y., Dunant A., Sekula P., Mockenhaupt M., Wolkenstein P., Valeyrie-Allanore L. et al. The role of prior corticosteroid use on the clinical course of Stevens - Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies. Br. J. Dermatol. 2012;167(3):555–562. DOI: 10.1111/j.1365-2133.2012.11074.x.

18. Pereira F.A., Mudgil A.V., Rosmarin D.M. Toxic epidermal necrolysis. J. Am. Acad. Dermatol. 2007;56(2):181–200. DOI: 10.1016/j.jaad.2006.04.048.

19.


Review

For citations:


Iamkina N.S., Boyarko V.V., Bukreeva E.V. Stevens – Johnson syndrome: a case report. Siberian Journal of Clinical and Experimental Medicine. 2023;38(2):248-252. (In Russ.) https://doi.org/10.29001/2073-8552-2023-38-2-248-252

Views: 770


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2713-2927 (Print)
ISSN 2713-265X (Online)